Thykn (India)International

Thykn (India) International, located in Mumbai, operates as a group company of Symbiotec Pharmalab Ltd. The entity was established to support and enhance the export of corticosteroid derivatives and other active pharmaceutical ingredients (APIs) manufactured by Symbiotec Pharmalab worldwide. The company highlights its role in expanding its international reach, with exports to around 30 countries. A key aspect of its profile is the emphasis on quality documentation and regulatory compliance to meet global requirements. The underlying philosophy centers on partnerships in progress, ensuring total customer satisfaction, and upholding patent and intellectual property rights while pursuing continuous improvement and strong relationships with partners.

From the information provided, Thykn (India) International appears to position itself as part of a broader pharmaceutical export ecosystem, leveraging the established quality standards and regulatory approvals associated with its manufacturing group. Notably, the factory (Symbiotec Pharmalab Ltd.) has WHOGMP and EUGMP certifications and has undergone USFDA inspections, with additional certification anticipated around 2009. While these regulatory milestones underscore the company’s quality assurances, there is no explicit detail in the source material about logistics capabilities, freight forwarding services, or supply chain operations specifically offered by Thykn (India) International. The content emphasizes export growth, regulatory readiness, and collaboration with customers rather than describing transportation, warehousing, or freight management offerings.

Given the information available, this profile focuses on the company’s background, regulatory standing, and export orientation. No concrete specialties related to freight forwarding can be confirmed from the provided sources, and no public contact details are included in the material.